Goldman Sachs’s New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a NFH.WS Stock Holding History

Goldman Sachs’s Portfolio NFH.WS Stock Details NFH.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-50,000	Closed	-$141K	–	6871
2021 Q3	$141K	Hold	50,000	–	–	﹤0.01%	5838
2021 Q2	$124K	Hold	50,000	–	–	﹤0.01%	5893
2021 Q1	$146K	Hold	50,000	–	–	﹤0.01%	5750
2020 Q4	$109K	Hold	50,000	–	–	﹤0.01%	5280
2020 Q3	$88K	Hold	50,000	–	–	﹤0.01%	5111
2020 Q2	$68K	Hold	50,000	–	–	﹤0.01%	5040
2020 Q1	$47K	Hold	50,000	–	–	﹤0.01%	5063
2019 Q4	$76K	Buy	+50,000	New	+$70.5K	﹤0.01%	5084

Other funds holding NFH.WS

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

MAM

Myriad Asset Management North Point, Hong Kong $722M AUM 11.94% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

AMH

Aspex Management (HK) Central, Hong Kong $8.89B AUM 39.91% 1-Year Est. Return

SVI

Strategic Vision Investment Hong Kong $157M AUM 125.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Goldman Sachs's NFH.WS Position: Q4 2021 in Review

Goldman Sachs sold out of New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a (NFH.WS) in Q4 2021, closing a stake of 50,000 shares — an estimated $141K sold.

Goldman Sachs first reported a position in NFH.WS in Q4 2019 and held it in 8 quarters. The position peaked at $146K in Q1 2021. 9 funds tracked by Wall St. Rank hold NFH.WS as of Q4 2021.

Goldman Sachs reported no remaining New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a position as of Q4 2021 after selling out during the quarter.
Goldman Sachs sold 50,000 New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a shares in Q4 2021, an estimated $141K.
Goldman Sachs first reported a position in New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a in Q4 2019 and held it in 8 quarters.
Goldman Sachs's New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a position peaked at $146K in Q1 2021.
9 funds tracked by Wall St. Rank held New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a as of Q4 2021.

Based on Goldman Sachs's 13F filing for Q4 2021, filed 14 Feb 2022.